COVID-19 Diagnosis in Computerized Tomography (CT) and X-ray Scans Using Capsule Neural Network.

This study proposes a deep-learning-based solution (named CapsNetCovid) for COVID-19 diagnosis using a capsule neural network (CapsNet). CapsNets are robust for image rotations and affine transformations, which is advantageous when processing medical imaging datasets. This study presents a performance analysis of CapsNets on standard images and their augmented variants for binary and multi-class classification. CapsNetCovid was trained and evaluated on two COVID-19 datasets of CT images and X-ray images. It was also evaluated on eight augmented datasets. The results show that the proposed model achieved classification accuracy, precision, sensitivity, and F1-score of 99.929%, 99.887%, 100%, and 99.319%, respectively, for the CT images. It also achieved a classification accuracy, precision, sensitivity, and F1-score of 94.721%, 93.864%, 92.947%, and 93.386%, respectively, for the X-ray images. This study presents a comparative analysis between CapsNetCovid, CNN, DenseNet121, and ResNet50 in terms of their ability to correctly identify randomly transformed and rotated CT and X-ray images without the use of data augmentation techniques. The analysis shows that CapsNetCovid outperforms CNN, DenseNet121, and ResNet50 when trained and evaluated on CT and X-ray images without data augmentation. We hope that this research will aid in improving decision making and diagnostic accuracy of medical professionals when diagnosing COVID-19.

Outcome prediction with serial neuron-specific enolase and machine learning in anoxic-ischaemic disorders of consciousness.

BACKGROUND: The continuation of life-sustaining therapy in critical care patients with anoxic-ischemic disorders of consciousness (AI-DOC) depends on prognostic tests such as serum neuron-specific enolase (NSE) concentration levels. OBJECTIVES: To apply predictive models using machine learning methods to examine, one year after onset, the prognostic power of serial measurements of NSE in patients with AI-DOC. To compare the discriminative accuracy of this method to both standard single-day, absolute, and difference-between-days, relative NSE levels. METHODS: Classification algorithms were implemented and K-nearest neighbours (KNN) imputation was used to avoid complete case elimination of patients with missing NSE values. Non-imputed measurements from Day 0 to Day 6 were used for single day and difference-between-days. RESULTS: The naive Bayes classifier on imputed serial NSE measurements returned an AUC of (0.81±0.07) for n=126 patients (100 poor outcome). This was greater than logistic regression (0.73±0.08) and all other classifiers. Naive Bayes gave a specificity and sensitivity of 96% and 49%, respectively, for an (uncalibrated) probability decision threshold of 90%. The maximum AUC for a single day was Day 3 (0.75) for a subset of n=79 (61 poor outcome) patients, and for differences between Day 1 and Day 4 (0.81) for a subset of n=46 (39 poor outcome) patients. CONCLUSION: Imputation avoided the elimination of patients with missing data and naive Bayes outperformed all other classifiers. Machine learning algorithms could detect automatically discriminatory features and the overall predictive power increased from standard methods due to the larger data set. CODE AVAILABILITY: Data analysis code is available under GNU at: https://github.com/emilymuller1991/outcome_prediction_nse.